Targeting mutant p53 for cancer therapy: direct and indirect strategies
J Hu, J Cao, W Topatana, S Juengpanich, S Li… - Journal of hematology & …, 2021 - Springer
TP53 is a critical tumor-suppressor gene that is mutated in more than half of all human
cancers. Mutations in TP53 not only impair its antitumor activity, but also confer mutant p53 …
cancers. Mutations in TP53 not only impair its antitumor activity, but also confer mutant p53 …
[HTML][HTML] Autophagy in health and disease: A comprehensive review
Autophagy, a conserved catabolic process, plays an immensely significant role in a variety
of diseases. However, whether it imparts a protective function in diseases remains …
of diseases. However, whether it imparts a protective function in diseases remains …
Roles of autophagy in oxidative stress
HR Yun, YH Jo, J Kim, Y Shin, SS Kim… - International journal of …, 2020 - mdpi.com
Autophagy is a catabolic process for unnecessary or dysfunctional cytoplasmic contents by
lysosomal degradation pathways. Autophagy is implicated in various biological processes …
lysosomal degradation pathways. Autophagy is implicated in various biological processes …
Neuronal death mechanisms and therapeutic strategy in ischemic stroke
R Mao, N Zong, Y Hu, Y Chen, Y Xu - Neuroscience bulletin, 2022 - Springer
Ischemic stroke caused by intracranial vascular occlusion has become increasingly
prevalent with considerable mortality and disability, which gravely burdens the global …
prevalent with considerable mortality and disability, which gravely burdens the global …
The complexity of p53-mediated metabolic regulation in tumor suppression
Although the classic activities of p53 including induction of cell-cycle arrest, senescence,
and apoptosis are well accepted as critical barriers to cancer development, accumulating …
and apoptosis are well accepted as critical barriers to cancer development, accumulating …
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …
M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …
Mutant p53 in cancer therapy—the barrier or the path
Since wild-type p53 is central for maintaining genomic stability and preventing oncogenesis,
its coding gene TP53 is highly mutated in~ 50% of human cancers, and its activity is almost …
its coding gene TP53 is highly mutated in~ 50% of human cancers, and its activity is almost …
The dual role of autophagy in cancer development and a therapeutic strategy for cancer by targeting autophagy
CW Yun, J Jeon, G Go, JH Lee, SH Lee - International journal of …, 2020 - mdpi.com
Autophagy is a delicate intracellular degradation process that occurs due to diverse stressful
conditions, including the accumulation of damaged proteins and organelles as well as …
conditions, including the accumulation of damaged proteins and organelles as well as …
Targeting autophagy using metallic nanoparticles: A promising strategy for cancer treatment
Despite the extensive genetic and phenotypic variations present in the different tumors, they
frequently share common metabolic alterations, such as autophagy. Autophagy is a self …
frequently share common metabolic alterations, such as autophagy. Autophagy is a self …
p53-mediated molecular control of autophagy in tumor cells
M Mrakovcic, LF Fröhlich - Biomolecules, 2018 - mdpi.com
Autophagy is an indispensable mechanism of the eukaryotic cell, facilitating the removal and
renewal of cellular components and thereby balancing the cell's energy consumption and …
renewal of cellular components and thereby balancing the cell's energy consumption and …